• 1
    Altman D, Carroli G, Duley L et al. for Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet 2002; 359: 18771890.
  • 2
    Kuban KCK, Leviton A, Pagano M, Fenton T, Strassfeld R, Wolff M. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992; 7: 7076.
  • 3
    Vink R, McIntosh TK, Faden AI. Magnesium in neurotrauma: Its role and therapeutic implications. In: Strata P, Carbone E (eds). Magnesium and Excitable Membranes. Berlin: Springer-Verlag, 1991; 125145.
  • 4
    McIntosh TK. Novel pharmacological therapies in the treatment of experimental traumatic brain injury: A review. Neurotrauma 1993; 10: 215261.
  • 5
    Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95: 263269.
  • 6
    Hauth JC, Goldenberg RL, Nelson KG, DuBard MB, Peralt MA, Gaudier FL. Reduction of cerebral palsy with maternal MgSO4 treatment in newborns weighing 500–1000 g. Am J Obstet Gynecol 1995; 172: 419.
  • 7
    Rouse DJ, Hirtz DG, Thom E et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359: 895905.
  • 8
    Atkinson MW, Belfort MA, Saade GR, Moise KJ. The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 1994; 83: 967970.
  • 9
    Carlan SJ, O'Brien WF. The effect of magnesium sulfate on the biophysical profile of normal term fetuses. Obstet Gynecol 1991; 77: 681684.
  • 10
    Levene M, Blennow M, Whitelaw A, Hankø E, Fellman V, Hartley R. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child 1995; 73: F174F177.
  • 11
    Petersen OB, Skajaa K, Svane D, Gregersen H, Forman A. The effects of dihydralazine, labetalol and magnesium sulphate on the isolated, perfused human placental cotyledon. BJOG 1994; 101: 871878.
  • 12
    Mittendorf R, Dambrosia J, Pryde PG et al. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in children. Am J Obstet Gynecol 2002; 186: 11111118.
  • 13
    Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. AJOG 2004; 190: 15201526.
  • 14
    Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: A randomized controlled trial. Obstet Gynecol 2003; 101: 217220.
  • 15
    Karsdorp VHM, van Vugt JMG, van Geijn HP et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994; 344: 16641668.
  • 16
    Yoon BH, Lee CM, Kim SW. An abnormal umbilical artery waveform: A strong and independent predictor of adverse perinatal outcome in patients with preeclampsia. Am J Obstet Gynecol 1994; 171: 713721.
  • 17
    Skajaa K, Svane D, Anderson KE, Forman A. Effects of magnesium and isradipine on contractile activation induced by the thromboxane A2 analog U46619 in human uteroplacental arteries in term pregnancy. Am J Obstet Gynecol 1990; 163: 13231333.
  • 18
    Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 1997; 12: 167172.
  • 19
    Lacin S, Demir N, Koyuncu F, Goktay Y. Value of intraplacental villous artery doppler measurements in severe pre-eclampsia. J Postgrad Med 1996; 42: 101104.
  • 20
    Baschat AA, Gembruch U. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003; 21: 124127.
  • 21
    Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol 2005; 192: 937944.
  • 22
    Tarzamni MK, Nezami N, Sobhani N, Eshraghi N, Tarzamniand M, Talebi Y. Nomograms of Iranian fetal middle cerebral artery Doppler waveforms and uniformity of their pattern with other populations' nomograms. BMC Pregnancy Childbirth 2008; 8: 50.
  • 23
    Belfort MA, Saade GR, Kenneth JM. The effect of magnesium sulfate on maternal and fetal blood flow in pregnancy-induced hypertension. Acta Obstet Gynecol Scand 1993; 72: 526530.
  • 24
    Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: A brief review. Stroke 2009; 40: 11691175.
  • 25
    Belfort MA, Saade GR, Suresh M, Johnson D, Vedernikov YP. Human umbilical vessels: Responses to agents frequently used in obstetric patients. Am J Obstet Gynecol 1995; 172: 13951403.
  • 26
    Harper A, Murnaghan GA. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. BJOG 1991; 98: 453459.
  • 27
    Swartz AE, Ruma MS, Kim E, Herring AH, Menard MK, Moise KJ Jr. The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery. Obstet Gynecol 2009; 113: 12251229.
  • 28
    Harrington K, Carpenter RG, Nguyen M, Campbell S. Changes observed in Doppler studies of the fetal circulation in pregnancies complicated by pre-eclampsia or the delivery of a small-for-gestational-age baby. I. Cross-sectional analysis. Ultrasound Obstet Gynecol 1995; 6: 1928.